VBI Vaccines Inc/BC (VBIV) Financial Statements
VBI Vaccines Inc/BC (VBIV) files with the U.S. Securities and Exchange Commission under CIK 0000764195. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2023
- Revenue
- $8.68 million
- Net Income
- -$92.84 million
- Total Assets
- $86.95 million
- Net Cash from Operations
- -$60.88 million
Fiscal year ended Dec 31, 2023. Latest periodic SEC filing: May 15, 2024. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for VBIV in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History